Lot# LMS081423-4
CTPharma - Tested Jan 11, 2024
21.97%
Total Δ9-THC
Total CBD
1.24%
Total Terpenes
THC-A converts to THC when heated (decarboxylation). Total Δ9-THC = (Δ9-THC) + (THC-A × 0.877) per NYS regulation.
11 tests reported
2 more detected.
As, Cd, Pb, Hg
ND
| Analyte | Result | Limit | Status |
|---|---|---|---|
| As, Cd, Pb, Hg | - | Unknown |
Aspergillus (flavus, fumigatus, terreus, niger)
Not Detected
Enteropathogenic E. coli
Not Detected
Listeria Monocytogenes
Not Detected
Salmonella species
Not Detected
Shiga Toxin Producing E. coli
Not Detected
Total Aerobic Microbial Count
4,200
Total Yeast & Mold Count
3,800 cfu/g
| Analyte | Result | Limit | Status |
|---|---|---|---|
| Aspergillus (flavus, fumigatus, terreus, niger) | Not Detected | - | Unknown |
| Enteropathogenic E. coli | Not Detected | - | Unknown |
| Listeria Monocytogenes | Not Detected | - | Unknown |
| Salmonella species | Not Detected | - | Unknown |
| Shiga Toxin Producing E. coli | Not Detected | - | Unknown |
| Total Aerobic Microbial Count | 4,200 | 100,000 | Unknown |
| Total Yeast & Mold Count | 3,800 cfu/g | 100,000 cfu/g | Unknown |
Aflatoxins (B1, B2, G1, G2)
ND
Ochratoxin-A
ND
| Analyte | Result | Limit | Status |
|---|---|---|---|
| Aflatoxins (B1, B2, G1, G2) | 20 ppb | Pass | |
| Ochratoxin-A | 20 ppb | Pass |
Per Sample ≥ 0.5g
ND
| Analyte | Result | Limit | Status |
|---|---|---|---|
| Per Sample ≥ 0.5g | - | Unknown |
Community Notes
Sign in to add a note.
No notes yet
Be the first to share your thoughts on this product.
Similar Products
Based on terpene profile similarity
Client Info
Lazy River Products, LLC
Lot: 2-JJ-F8-06182024
7 shared terpenes
CT Vice 1g Pre Roll (H) 00635
Curaleaf
7 shared terpenes
Shoreline Shakedown 1g Pre Roll (H) 00561
Curaleaf
7 shared terpenes
PGMO
Cirona Labs
Lot: KR-C-PGMO-250929
6 shared terpenes
Purple Milk 1g Infused Pre Roll (I) 00640
Curaleaf
7 shared terpenes
Details
- Product Type
- N/A
- Lot/Batch
- LMS081423-4
- Sample ID
- N/A
- Laboratory
- NORTHEAST LABORATORIES
- Lab Permit
- ACTL.0000004
- Analysis Date
- Jan 11, 2024